CUE-101, a novel HPV16 E7:pMHC:IL-2:Fc fusion protein, enhances tumor antigen specific T cell activation for the treatment of HPV16-driven malignanciesSteven Quayle,Natasha Girgis,Dharma Raj Thapa,Zohra Merazga, Miguel Moreta, Sandrine Hulot, Alyssa Nelson, Lauren Kraemer, Dominic Beal,Mark Haydock,Luke Witt, Jessica Ryabin,Jonathan Soriano,Emily Spaulding,John Ross, Rodolfo Chaparro,Ronald Seidel,Anish Suri,Saso Cemerski,Kenneth Pienta,Mary SimcoxJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
